Therapeutic Group

Indication Dosage

Exemestane is a medication primarily indicated for the treatment of postmenopausal women with hormone receptor-positive early breast cancer after they have completed 2-3 years of tamoxifen therapy. It is also prescribed for postmenopausal women with advanced breast cancer whose disease has progressed following anti-estrogen therapy. Exemestane works by reducing the production of estrogen in the body, thereby helping to slow down the growth of hormone-sensitive breast tumors. 

Adjuvant Treatment Of Oestrogen-receptor-positive Early Breast Cancer In Postmenopausal Women Following2-3 Years Of Tamoxifen Therapy, Advanced Breast Cancer in Postmenopausal Women In Whom Anti-oestrogen therapy Has Failed: 

• Adult: 25 Mg Daily After A Meal. In Early Breast Cancer, Continue Treatment Until Completion Of 5 Yr Combined Sequential Adjuvant Therapy With Tamoxifen, Or Earlier If the Tumour Relapses. In Advanced Breast Cancer Continue Treatment Until Subsided. 
• Children: Not Recommended.

Content

Pregnancy

Contraindicated In Pregnancy.

Stability

Contra Indications

Precautions

Lactation

Side Effects